HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ryan Aleong Selected Research

bucindolol

2/2022Dose-limiting, adverse event-associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trial.
1/2021Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the ADRB1 Arg389Arg Genotype.
1/2019Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF Trial.
3/2013Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ryan Aleong Research Topics

Disease

5Atrial Fibrillation
02/2022 - 07/2008
4Heart Failure
02/2022 - 03/2013
1Bradycardia
02/2022
1Ventricular Premature Complexes (Premature Ventricular Contraction)
10/2019
1Pericarditis
11/2007

Drug/Important Bio-Agent (IBA)

4bucindololIBA
02/2022 - 03/2013
2Metoprolol (Toprol-XL)FDA LinkGeneric
02/2022 - 01/2019
1Polyvinyl Chloride (PVC)IBA
10/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2007
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
11/2007

Therapy/Procedure

2Catheter Ablation
07/2008 - 11/2007
1Therapeutics
02/2022
1Drug Tapering
02/2022
1Catheters
11/2007